SporeGen® awarded SAPHIR Grant

  • May 22, 2015
  • SporeGen

The SAPHIR project is an EU funded project whose full title is: Strengthening Animal Production and Health through the Immune Response.

The general objective of SAPHIR is to generate effective vaccination strategies towards the control of endemic pathogens responsible for major economic losses in livestock, leading to improved viability,sustainability and profitability of food animal production systems, improved animal welfare, and reduced xenobiotic usage in farming. To bring effective vaccines to the market, SAPHIR will aim to i) demonstrate the efficacy, safety and cost-effectiveness of promising vaccines against a selection of endemic pathogens to provide “at least two vaccines at the demonstration level”, ii) design innovative cutting edge vaccine strategies using up-to-date scientific and technological advances and iii) generate new knowledge in livestock vaccinology.

SporeGen® has begun collaborative work with the University of Ghent, working on the use of Eimeria and Bacillus strains expressing C. perfringens antigens to prevent necrotic enteritis in broilers.

More information on the project can be found here : http://www.h2020-saphir.eu/